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Of the fungi pathogenic to man, perhaps more ip 
known about Coccidioides immitis than any Äther. 
This knowledge which has been accumulated 
within the past 50 years has brought the following 
facts to light.
C. immitis is  a dimorphic organism, i.e ., it exists 
in two separate and distinct phases, one in living 
tissue and the other in laboratory media. In animal 
tissue it occurs in the form of spherical bodies 
known as spherules or sporangia (figure 1). These 
structures at maturity are filled with a varying 
number of endospores that are released through 
rupture of the s p o r a n g i a l  wall. The liberated 
spores may each, in turn, develop into new spo­
rangia and by this method the fungus may continue 
to multiply within the animal body.
On artificial media, C. immitis develops in the
form of a mold-like fungus not unlike that of many 
nonpathogenic fungi. The white cottony colonies, 
however, from numerous small, more or less rec­
tangular thick-walled arthrospores that are of 
diagnostic importance (figure 2). When spores or 
mycelial fragments are inoculated onto suitable 
media, the mold-like colony again develops. On 
the other hand, sporangia appear when the same 
cultural elements are injected into animals. At 
the present time, the tissue  phase of C• immitis 
cannot be obtained with any degree of regularity 
on artificial media.
The d isease induced by C. immitis is  known 
as coccidioidomycosis and was formerly believed 
to be rare and invariably fatal. Today i t  is known 
that millions of p e o p l e  have been infected in 
several of our western States; and although fatal 
manifestations are rare, the symptoms induced
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may be quite severe.
Skin testing  surveys and clinical records show 
that more than 99 percent of all infections are 
mild and self-limited. In fact, about 60 percent of 
all infections are either completely asymptomatic 
or are accompanied by vague, insignificant symp­
toms. The remaining nonfatal infections are char­
acterized either by respiratory disturbances resem­
bling those of influenza and pneumonia or by the 
development of a variety of more or le s s  severe 
symptoms.
In white persons, progressive disease develops 
in only 0.2 percent or le ss  of all infections, but 
in these disseminated cases mortality averages 
50 percent. The incidence of severe infections 
appears to be higher in other racial groups, but 
not enough data has been accumulated to substan­
tiate this impression. Although these s ta tis tic s , 
gathered principally from California, would indi­
cate that coccidioidomycosis is  not the invariably 
fatal d isease it was once considered to be, we 
lack morbidity and mortality data from all the 
endemic areas.
From an epidemiological point of view, C. immi­
tis  is  a highly i n t e r e s t i n g  organism. It has a 
markedly limited geographic distribution for rea­
sons that are not yet understood. At the present 
time, C. immitis is  known to exist solely in sev­
eral arid regions of North and South America with 
a possible small endemic focus in Italy. In the 
United States, i t  has been found in portions of 
California, Arizona, New Mexico, Nevada, Utah, 
and Texas.
Until recently, Argentina was the only South 
American country where cases of coccidioido­
mycosis were known to occur. Recent findings, 
however, show that the organism exists in P ara ­
guay, Bolivia, Venezuela, and Mexico. It is not 
unreasonable to expect that, in time, C■ immitis 
will be found to be d i s t r i b u t e d  in suitable 
environments elsewhere.
C. immitis probably exists as a saprophyte in 
nature. In fact, it has been isolated from soil by 
several workers. All e v i d e n c e  indicates that 
coccidioidomycosis is  essentially  an air-borne 
disease. Incidence of infection is  highest during 
dry, dusty periods and lowest during rainy seasons. 
Recent s t u d i e s  have shown that dust control 
measures significantly reduce the incidence of 
infection of humans by C. immitis. There are no 
records of person-to-person transmission.
SUMMARY
This presentation has summarized briefly some 
of the knowledge of Coccidioides immitis that has 
been accumulated since Posadas, of Argentina, 
described the first case of coccidioidomycosis in 
1892 and Ophuls (1900) showed, by successful 
isolation, that the etiologic agent was a fungus 
and not a protozoan.
To medical and public health workers, C. immitis 
s till presents many problems. Because coccidioi­
domycosis is  a protean d isease which simulates 
syphilis, pneumonia, m easles, tuberculosis, and 
other d iseases, differential diagnosis in this in­
fection is an important problem for the physician. 
Competent mycological laboratory work is neces­
sary to guide the physician in his diagnosis.
It is unfortunate that, at the present time, once 
a correct diagnosis of coccidioidomycosis has 
been made there is  available little  besides sup­
portive measures to aid the patient. No immuno­
logical or chemotherapeutic tools are yet available 
to control the d isease . In the p r e v e n t i o n  and 
therapy of this and most other mycoses, the micro­
biologist, chemist, and immunologist have an 
unlimited field for investigation.
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